By Deron Hamel Results from an early phase clinical trial suggest that cannabidiol (CBD) may be an effective treatment for stemming the number of seizures for people living with severe, drug-resistant forms of epilepsy, however, randomized controlled trials are needed before conclusions can be drawn on the chemical compound’s effectiveness, says Dr. Elizabeth Donner. While…
Update (July 6, 2015): The acetazolamide shortage has been resolved. Acetazolamide tablets are available again from AA Pharma. The Drug Identification Number or DIN is 00545015. Please note that Acetazolam (Valeant Canada LP) is no longer available, this product has been discontinued. Drug Identification Number or DIN is 00295019. If you need any assistance please let…
By Deron Hamel The operations manager of the Ministry of Health and Long-Term Care’s Exceptional Access Program (EAP) says a March 26 educational session delivered to staff members from the Ontario public drug programs division enhanced people’s understanding of epilepsy and the issues faced by those living with the condition. Richard Lin says the lunchtime…
By Deron Hamel Dr. Carter Snead says the best possible long-term result from new provincial epilepsy-care guidelines would be for primary-care physicians, neurologists and patients to use the standards to enhance care of Ontarians with seizure disorders. The Provincial Guidelines for the Management of Epilepsy in Adults and Children creates a framework for general practitioners…
Sponsor Image 1
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
